About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Texas | 42,097 Studies Near You

Clinical TrialsTexas

Clinical Trials in Texas

Discover 42,097 clinical trials near Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6821-6840 of 42,097 trials

TerminatedSafety, Tolerability and Pharmacodynamics of SYNB1020This Phase 1b/2a, randomized, double-blind, placebo-controlled study was designed to evaluate the safety, tolerability, and pharmacodynamics of SYNB1020 in hepatic insufficiency…NCT03447730·Coronado, California and 4 others CompletedInhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of OsteosarcomaRATIONALE: Inhaling aerosolized sargramostim before and after surgery may interfere with the growth of tumor cells and shrink the tumor so that it can be removed during surgery.NCT00066365·Birmingham, Alabama and 92 others

Find Trials by Condition in Texas

Breast Cancerin Texas Lung Cancerin Texas Prostate Cancerin Texas Colorectal Cancerin Texas Melanomain Texas Leukemiain Texas Lymphomain Texas Pancreatic Cancerin Texas Ovarian Cancerin Texas Brain Cancerin Texas Diabetesin Texas

Data from ClinicalTrials.govTerms

CompletedA Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD)This is an outpatient, 2-arm, Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of REL-1017 once daily (QD) as a…NCT05081167·Maitland, Florida and 9 others

CompletedA Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors.Evaluate the safety, tolerability and the tolerated maximum dose of MEDI-575 in adult subjects with advanced solid tumors refractory to standard therapy or for which no standard…NCT00816400·Denver, Colorado and 4 others

CompletedEfficacy and Safety of Levalbuterol Versus Racemic Albuterol in AsthmaTo investigate the Efficacy and Safety of Levalbuterol versus Racemic Albuterol in the Treatment of Acute Asthma.NCT00667407·Hoover, Alabama and 27 others

RecruitingA Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsThis is a first-in-human, Phase 1/2 study to evaluate LCB84, a TROP2-directed antibody-drug conjugate, alone and in combination with an anti-PD-1 Ab, in dose escalation (Phase 1)…NCT05941507·Los Angeles, California and 7 others

TerminatedMRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain RadiationThis study determines whether non-invasive evaluation using repeated magnetic resonance imaging (MRI) scans and repeated blood biomarker measurements can be used to predict…NCT05087888·Houston, Texas

Active not recruitingEffect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and renal impairment, with inadequate…NCT06297603·Huntsville, Alabama and 75 others

Active not recruitingTreatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® MoleculeThis is a randomized, placebo-controlled, parallel group, multicenter, double-blind Phase 2a, 2-arm study.NCT06812988·Atlanta, Georgia and 23 others

CompletedEsomeprazole for Treatment of GERD in Pediatric PatientsTo look at the safety and improvement in symptoms of a once a day dosing of esomeprazole in children 1 to 11 years old with inflammation of their esophagus or food pipe…NCT00228527·Mobile, Alabama and 35 others

Active not recruitingA Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing CancersThis study will evaluate the safety, tolerability, and pharmacokinetics of Runimotamab administered intravenously as a single agent and in combination with Trastuzumab in…NCT03448042·New Haven, Connecticut and 25 others

UnknownStudy of AAVrh10-h.SGSH Gene Therapy in Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA)MPS IIIA is predominantly a central nervous system disease causing cognitive disability, progressive loss of acquired skills, behavioral and sleep disturbance.NCT03612869·Orange, California and 7 others

TerminatedAn Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain MetastasisThis is a multicenter, randomized open-label Phase 2 study to assess the safety, efficacy and pharmacokinetic (PK) of 2 dosing regimens of encorafenib + binimetinib combination in…NCT03911869·Los Angeles, California and 24 others

CompletedStudy of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCLThe purpose of this study is to compare the progression free survival of KW-0761 versus vorinostat for subjects with relapsed or refractory CTCL.NCT01728805·Birmingham, Alabama and 72 others

CompletedAdaptive COVID-19 Treatment Trial (ACTT)This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with…NCT04280705·Birmingham, Alabama and 59 others

CompletedIdarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid LeukemiaThis phase I/II trial is studying the side effects and best dose of tipifarnib when given with idarubicin and cytarabine and to see how well it works in treating patients with…NCT00096122·Houston, Texas

RecruitingA Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With CancerThe purpose of this study is to check how well LY35327021 works and how safe it is for controlling nausea and vomiting caused by chemotherapy.NCT07169851·Greenbrae, California and 66 others

CompletedRole of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter AblationThe purpose of this study is to assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome To evaluate the inflammatory…NCT02208102·Austin, Texas

CompletedA 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular DegenerationEYE-TIE-201 is a 2-part study to investigate the safety and effectiveness of a new drug being developed called EYE201.NCT06664502·Scottsdale, Arizona and 26 others

Not yet recruitingBiobehavioral Mechanisms of Activity and Loss of Control Eating in ChildrenLoss of control eating in children and adolescents is associated with a host of negative physical and psychological health outcomes and a prognostic marker for development of…NCT07823153·Los Angeles, California and 2 others

PreviousPage 342 of 2105Next

Heart Diseasein Texas